ID

34476

Description

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01368055

Link

https://clinicaltrials.gov/show/NCT01368055

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/27/19 5/27/19 -
  3. 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT01368055

Eligibility Prostate Cancer NCT01368055

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate cancer.
Description

ID.1

Data type

boolean

gleason score 2-6 or 7.
Description

ID.2

Data type

boolean

psa ≤ 20 ng/ml.
Description

ID.3

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer surgery or pelvic radiation.
Description

ID.4

Data type

boolean

prior/concurrent systemic chemotherapy for prostate cancer.
Description

ID.5

Data type

boolean

active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
Description

ID.6

Data type

boolean

history of hip replacement.
Description

ID.7

Data type

boolean

prior intrapelvic surgery.
Description

ID.8

Data type

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
Description

ID.9

Data type

boolean

receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
Description

ID.10

Data type

boolean

Similar models

Eligibility Prostate Cancer NCT01368055

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
prostate cancer.
boolean
ID.2
Item
gleason score 2-6 or 7.
boolean
ID.3
Item
psa ≤ 20 ng/ml.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
previous prostate cancer surgery or pelvic radiation.
boolean
ID.5
Item
prior/concurrent systemic chemotherapy for prostate cancer.
boolean
ID.6
Item
active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
boolean
ID.7
Item
history of hip replacement.
boolean
ID.8
Item
prior intrapelvic surgery.
boolean
ID.9
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
boolean
ID.10
Item
receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial